Cell Therapeutics, Inc. (Nasdaq: CTIC) is higher in pre-open action after the company announced an exclusive worldwide licensing agreement with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE